Our Team

Spiros Jamas, ScD

Spiros Jamas, ScD joined Mass General Brigham Innovation as Entrepreneur in Residence, working closely with Meredith Fisher, partner of the Innovation Fund, on the launch of an exciting new company focused on discoveries related to beneficial commensal viruses for the treatment of cancer and autoimmune diseases.

Spiros is a biotech entrepreneur with over 30 years of senior management experience in the biopharmaceutical industry. He has served as CEO and/or founder of high growth, innovation-driven companies in the fields of immunology, inflammation, microbiome and infectious diseases. He has assembled high-performance teams to grow these organizations and led first-in-class R&D programs from early discovery through Investigational New Drug Application (IND) submissions and into advanced clinical development.

Over the course of his career, Dr. Jamas has raised over $300 million in funding from a variety of sources including public and private equity and debt.  In addition to his significant experience in building biopharma companies, Dr. Jamas was the Global Healthcare Analyst in the Global Fundamental Strategies group at State Street Global Advisors, the world’s second largest asset management firm.

Dr. Jamas obtained a Doctor of Science in Biotechnology from M.I.T. in 1987 and a Bachelor of Science in Chemical Engineering from U.M.I.S.T in 1981.